Skip to main content
Clinical Trials/IRCT20111107008022N8
IRCT20111107008022N8
Recruiting
未知

Comparative bioequivalence study of two different Pantoprazole 40mg formulations (Exir Pharmaceutical Company & reference) in 24 Iranian volunteers

Exir Pharmaceutical Company0 sites24 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health volunteers.
Sponsor
Exir Pharmaceutical Company
Enrollment
24
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Exir Pharmaceutical Company

Eligibility Criteria

Inclusion Criteria

  • 24 healthy male and female volunteers will participate in this study
  • Aged 18 to 45 years based on laboratory safety tests
  • Paraclinical health based on tests performed
  • No history of diseases affecting drug pharmacokinetic processes
  • Lack of any chronic or acute medication at least 1 week before the start of the study
  • Adherence to the criteria on the basis of moral obligation and signed an informed consent
  • Actual weight (TBW) in the range of 20% IBW

Exclusion Criteria

  • Subject showed clinically relevant deviations from normal in physical examination.
  • Subject had undergone surgery of the gastro\-intestinal tract
  • Subject had donated a unit of blood or participated in another clinical trial, within the last three months before the first treatment
  • Subject had a history of alcohol abuse or smokes more than 10 cigarettes per day.
  • Use any medication within 14 days before the first treatment.
  • A history of allergic to biguanides

Outcomes

Primary Outcomes

Not specified

Similar Trials